E9-27630. Memorandum of Understanding Between the Food and Drug Administration and Waterfront Media  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between FDA and Waterfront Media. The purpose of the MOU is to extend the reach of FDA Consumer Health Information and to provide consumers with better information and timely content concerning public health and safety topics, including alerts of emerging safety issues and product recalls.

    DATES:

    The agreement became effective October 14, 2009.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Jason Brodsky, Consumer Health Information Staff, Office of External Relations (HFI-40), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-6251, e-mail: Jason.Brodsky@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.

    Start Signature

    Dated: November 12, 2009.

    David Horowitz,

    Assistant Commissioner for Policy.

    End Signature Start Printed Page 59572

    Start Printed Page 59573

    Start Printed Page 59574

    Start Printed Page 59575

    Start Printed Page 59576

    Start Printed Page 59577

    Start Printed Page 59578

    End Supplemental Information

    BILLING CODE 4160-01-S

    [FR Doc. E9-27630 Filed 11-17-09; 8:45 am]

    BILLING CODE 4160-01-C

Document Information

Comments Received:
0 Comments
Effective Date:
10/14/2009
Published:
11/18/2009
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
E9-27630
Dates:
The agreement became effective October 14, 2009.
Pages:
59571-59578 (8 pages)
Docket Numbers:
Docket No. FDA-2009-N-0667, FDA 225-09-0013
PDF File:
e9-27630.pdf